SCHEMBL901476

SCHEMBL901476

O=C(O)C1C[C@@H](F)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305909 1.00
SCHEMBL6196827 1.00
SCHEMBL187962 1.00
SCHEMBL900297 1.00
SCHEMBL661917 1.00
SCHEMBL16635328 1.00
SCHEMBL187963 1.00
SCHEMBL901466 1.00
Hydrochloric Acid SCHEMBL6201099 0.98 CYP2D6 (0.56)
Hydrochloric Acid SCHEMBL21598085 0.98 CYP2D6 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1007568-B1 COLLAGEN MIMICS WISCONSIN ALUMNI RES FOUND (US) 2007-08-29 EP claimed
EP-1007568-A1 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2000-06-14 EP claimed
US-5973112-A Collagen mimics WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-10-26 US claimed
WO-1999010381-A1 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-03-04 WO claimed
CN-113801215-A Cyclic citrullinated peptide, antigen containing same, reagent, kit and application 苏州携创生物技术有限公司 2021-12-17 CN disclosed
EP-2945952-B1 HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2019-08-28 EP disclosed
US-20190002480-A1 Silane-Containing Heterocyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases MERCK SHARP & DOHME CORP. (US) 2019-01-03 US disclosed
EP-3393585-A1 SILANE-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES Merck Sharp & Dohme Corp. (US) 2018-10-31 EP disclosed
EP-2621279-B1 FUSED TETRACYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2018-04-04 EP disclosed
WO-2017112531-A1 SILANE-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2017-06-29 WO disclosed
US-9555038-B2 Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2017-01-31 US disclosed
US-9504690-B2 Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2016-11-29 US disclosed
EP-1007568-B1 COLLAGEN MIMICS WISCONSIN ALUMNI RES FOUND (US) 2007-08-29 EP disclosed
EP-1539744-A4 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARM INC (US) 2007-06-06 EP disclosed
WO-2005105138-A2 COLLAGEN MIMICS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2005-11-10 WO disclosed
EP-1539744-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2005-06-15 EP disclosed
WO-2004007444-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2004-01-22 WO disclosed
EP-1007568-A1 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2000-06-14 EP disclosed
US-5973112-A Collagen mimics WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-10-26 US disclosed
WO-1999010381-A1 COLLAGEN MIMICS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-03-04 WO disclosed